MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Scene Induced emotion processing in Parkinson’s disease: BOLD-fMRI study

    S. Boujraf, M. Benzagmout, B. Alami, H. Amadou, H. El Hamdaoui, A. Bennani, M. Jaafari, I. Rammouz, M. Maaroufi, D. Boussaoud (Fez, Morocco)

    Objective: The aim of this study was to investigate emotional processing organization in the brain of patients with Parkinson's disease and to explore whether there…
  • 2019 International Congress

    Deep Brain Stimulation for atypical tremors secondary to Neuroferritinopathy: Single center experience

    S. Chandra, J. Randhawa, M. Schiess (Houston, TX, USA)

    Objective: To describe the clinical response to deep brain stimulation. Background: Neuroferritinopathy is a neurodegenerative disease in which mutations in the ferritin light polypeptide (FTL)…
  • 2019 International Congress

    Dry eye in Parkinson’s disease: symptoms, consequences and treatment options

    I. Csoti, N. Koleva-Alazeh (Leun, Germany)

    Objective: Dry eye is a common side effect of PD/PSP and easily manageable, yet its occurrence and debilitating ramifications are often unrecognized. The aim of…
  • 2019 International Congress

    Abnormal respiratory rate and patterns in MSA

    E. Driver-Dunckley, B. Goodman (Scottsdale, AZ, USA)

    Objective: To evaluate respiratory rate and patterns in patients with Multiple Systems Atrophy (MSA). Background: One of the primary clinical features of multiple system atrophy…
  • 2019 International Congress

    Nigral Iron Load as Diagnostic Parameter in Parkinson’s Disease

    S. Franthal, L. Pirpamer, N. Homayoon, M. Koegl, P. Katschnig-Winter, K. Wenzel, C. Langkammer, S. Ropele, F. Fazekas, R. Schmidt, P. Schwingenschuh (Graz, Austria)

    Objective: The aim of our study was to determine the diagnostic value of nigral iron depositions in PD, measured by iron specific MRI-techniques. Background: Nigral…
  • 2019 International Congress

    Synaptic dysfuncion in a Drosophila model of PARK14

    T. Hatano, A. Mori, T. Inoshita, K. Fukushima-Shiba, T. Koinuma, C. Yamashita, Y. Imai, N. Hattori (Tokyo, Japan)

    Objective: To investigate the association between lipid metabolism and synaptic function in Parkinson's disease (PD) due to PLA2G6 mutations. Background: The nervous system is enriched…
  • 2019 International Congress

    Impact of OFF periods on aspects of employment for people with Parkinson’s disease

    I. Iresha Abeynayake, L. Marinucci, M. Klingler, C. Kenney (Aardsley, NY, USA)

    Objective: To characterize the impact of OFF periods on aspects of employment for people with Parkinson’s disease (PD) who have OFF periods compared to those…
  • 2019 International Congress

    Association between hand functions, hand reaction time and balance in patients with idiopathic Parkinson’s disease

    AC. Kalkan, T. Kahraman, BO. Ugut, B. Donmez Colakoglu, A. Genc (Izmir, Turkey)

    Objective: To investigate the relationship between hand function, hand reaction time and balance in patients with idiopathic Parkinson's disease (PD). Background: Symptoms of PD such…
  • 2019 International Congress

    Is the personal Kinetigraph useful in the management of Parkinson´s disease patients? A retrospective study from a tertiary movement disorder center

    E. Krause, J. Randhawa, R. Mehanna (Houston, TX, USA)

    Objective: To assess the usefulness of the Personal KinetiGraph (PKG) in characterizing the intensity and timing of motor symptoms in Parkinson´s Disease (PD) patients. Background:…
  • 2019 International Congress

    CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease

    Y. Li, M. Niu, J. Liu (Shanghai, China)

    Objective: Activated microglia and increased cytokine levels could precede neurodegeneration in neuro-inflammation in A53T mice, and CXCL12 was found increased in plasma CNS-derived exosomes, which…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley